(Q46440391)

22 December 2017

title

Insulin and endothelin in the acute regulation of adiponectin in vivo in humans (English)

1 reference

22 December 2017

author name string

Lori A Brame

1

1 reference

22 December 2017

Robert V Considine

2

1 reference

22 December 2017

Mikako Yamauchi

3

1 reference

22 December 2017

Alain D Baron

4

1 reference

22 December 2017

Kieren J Mather

5

1 reference

22 December 2017

publication date

1 March 2005

1 reference

22 December 2017

published in

Obesity

1 reference

22 December 2017

volume

13

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

582-588

1 reference

22 December 2017

Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

A novel serum protein similar to C1q, produced exclusively in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Regulation of adiponectin secretion by endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Insulin decreases human adiponectin plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Circulating endothelin-1 levels in obese patients with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Activation of the endothelin system in insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Increased activity of endogenous endothelin in patients with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Chronic endothelin-1 treatment leads to insulin resistance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Endothelin-1-induced GLUT4 translocation is mediated via Galpha(q/11) protein and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ET(A) receptor and is co-mitogenic with growth factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.62

31 March 2020

Identifiers

DOI

10.1038/OBY.2005.62

1 reference

22 December 2017

PubMed ID

15833944

1 reference

22 December 2017